Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature

Anna Mathioudaki, Xizhe Wang, David Sedloev, Richard Huth, Aryan Kamal, Michael Hundemer, Yi Liu, Spyridoula Vasileiou, Premal Lulla, Carsten Müller-Tidow, Peter Dreger, Thomas Luft, Tim Sauer, Michael Schmitt, Judith B. Zaugg, Caroline Pabst

Blood (2024) 143 (13): 1269–1281.

https://doi.org/10.1182/blood.2023021815

Published: 2024

Includes: Supplemental data

Journal Articles

Immunological Subgroups Predicting Efficacy of Elotuzumab in Multiple Myeloma Patients: Insights from the GMMG-HD6 Clinical Trial

Blood (2023) 142 (Supplement 1): 1991.

https://doi.org/10.1182/blood-2023-189169

Published: 2023

Journal Articles

Bone Marrow Immune Signatures in Multiple Myeloma Are Linked to Tumor Heterogeneity and Treatment Outcome

Blood (2022) 140 (Supplement 1): 2083–2085.

https://doi.org/10.1182/blood-2022-168685

Published: 2022

Journal Articles

Macs - a Leukemic Stem Cell- Based Predictor of Clinical Response to Venetoclax and Other BH3 Mimetics for Acute Myeloid Leukemia

Simon Renders, Alexander Waclawiczek, Aino-Maija Leppä, Cecilia Reyneri, Barbara Betz, Karolin Stumpf, Maike Janssen, Julia M. Unglaub, Elisa Donato, Rabia Shahswar, Simon Raffel, Michael Heuser, Richard F. Schlenk, Michael Hundemer, Tim Sauer, Carsten Müller-Tidow, Andreas Trumpp

Blood (2022) 140 (Supplement 1): 2023–2024.

https://doi.org/10.1182/blood-2022-164831

Published: 2022

Journal Articles

Leukemic Stem Cells of Monocytic AMLs Are Not-Resistant to BCL-2 Inhibition

Simon Renders, Aino-Maija Leppä, Alexander Waclawiczek, Maike Janssen, Elisa Donato, Cecilia Reyneri, Julia M. Unglaub, Michael Hundemer, Richard F. Schlenk, Simon Raffel, Carsten Müller-Tidow, Tim Sauer, Andreas Trumpp

Blood (2021) 138 (Supplement 1): 3469.

https://doi.org/10.1182/blood-2021-149781

Published: 2021

Journal Articles

Impact of Novel Therapies on CD4-T-Cell-Numbers and Infectious Complications in Patients with Relapsed/Refractory Multiple Myeloma

Lukas John, Kaya Miah, Axel Benner, Elias K Mai, MD, Katharina Kriegsmann, MD, Michael Hundemer, MD, Carsten Mueller-Tidow, MD, Karin Jordan, MD, Hartmut Goldschmidt, MD, Marc S. Raab, MD, Nicola Giesen, MD

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-136686

Published: 2020

Journal Articles

The Bone Marrow Microenvironment of Multiple Myeloma Long-Term Survivors at Single Cell Resolution

Raphael Lutz, MD, Abdelrahman Mahmoud, Mohamed H.S. Awwad, Charles D. Imbusch, PhD, Tobias Boch, MD, Brian G.M. Durie, MD, Niels Weinhold, PhD, Marc S. Raab, MD, Carsten Müller-Tidow, MD, Simon Haas, PhD, Benedikt Brors, PhD, Hartmut Goldschmidt, MD, Michael Hundemer, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-142298

Published: 2020

Journal Articles

Characterization of Patients with Multiple Myeloma in Long- Term Remission

Raphael K. Lutz, MD, Katharina Kriegsmann, MD MBA, Mohamed H.S. Awwad, Carsten Müller-Tidow, MD, Gerlinde Egerer, Nicola Lehners, Marc S Raab, MD PhD, Brian GM Durie, MD, Michael Hundemer, Hartmut Goldschmidt, MD

Blood (2018) 132 (Supplement 1): 4508.

https://doi.org/10.1182/blood-2018-99-116039

Published: 2018

Journal Articles

The Prognostic and Predictive Value of IKZF1 and IKZF3 Expression in T-Cells in Patients with Multiple Myeloma

Mohamed H.S. Awwad, Katharina Kriegsmann, MD MBA, Julian Plaumann, Michael Benn, Jens Hillengass, MD, Marc-Steffen S Raab, Uta Bertsch, MD, Markus Munder, MD, Katja C. Weisel, Hans Jürgen Salwender, Mathias Hänel, MD, Roland Fenk, MD, Jan Dürig, MD, Carsten Müller-Tidow, Hartmut Goldschmidt, MD, Michael Hundemer

Blood (2017) 130 (Supplement 1): 1846.

https://doi.org/10.1182/blood.V130.Suppl_1.1846.1846

Published: 2017

Journal Articles

Target Expression, Preclinical Activity and Mechanism of Action of EM801: A Novel First-in-Class Bcma T-Cell Bispecific Antibody for the Treatment of Multiple Myeloma

Anja Seckinger, MD, Jose Antonio Delgado, Laura Moreno, Brigitte Neuber, PhD, Anna Grab, PhD, Susanne Lipp, MS, Juana Merino, MDPhD, Minh Diem Vu, PhD, Klaus Strein, MD PhD, Felipe Prosper, MDPhD, Michael Hundemer, MD, Jesus San Miguel, MDPhD, Dirk Hose, MD, Bruno Paiva, PhD

Blood (2015) 126 (23): 117.

https://doi.org/10.1182/blood.V126.23.117.117

Published: 2015

Journal Articles

A Single Center Comparison Between Two Different Apheresis Systems for Peripheral Blood Stem Cell Collections

Katharina Lisenko, MD, Thomas Bruckner, PhD, Michael Hundemer, MD, Anita Schmitt, MD, Joe Puthenparambil, MD, Petra Pavel, MD, Jens Hillengass, MD, Mathias Witzens-Harig, MD, Hartmut Goldschmidt, MD, Anthony D Ho, MD, Patrick Wuchter, MD

Blood (2015) 126 (23): 1900.

https://doi.org/10.1182/blood.V126.23.1900.1900

Published: 2015

Journal Articles

Detection and Characterization of Plasma Cell and B Cell Clones in Patients with Systemic Light Chain Amyloidosis Using Flow Cytometry

Stefan Schönland, MD, Ute Hegenbart, MD, Christoph Kimmich, Katarina Lisenko, MD, Dirk Hose, MD PhD, Hartmut Goldschmidt, MD, Anna Jauch, PhD, Anthony D. Ho, Prof., MD FRCPC, Michael Hundemer, MD

Blood (2014) 124 (21): 2068.

https://doi.org/10.1182/blood.V124.21.2068.2068

Published: 2014

Journal Articles

Validation of a Predictive Formula for Collection of Hematopoietic Progenitor Cells (HPC) By Leukapheresis at 2 Institutions Using 4 Different Machine Protocols

Eric R Rosenbaum, MD MPH, Patrick Wuchter, MD, Michael Hundemer, MD, Petra Pavel, MD, Mathias Witzens-Harig, MD, Hartmut Goldschmidt, MD, Bart Barlogie, MD PhD, Anthony Ho, MD, Michele H. Cottler-Fox, MD

Blood (2014) 124 (21): 2458.

https://doi.org/10.1182/blood.V124.21.2458.2458

Published: 2014

Journal Articles

Control Of Allograft Rejection With Mitomycin C Incubated Blood Cells

Johann Greil, MD, Christian Kleist, PhD, Elisabeth Mohr, PhD, Flavius Sandra-Petrescu, PhD, Lucian Jiga, MD, PhD, Laura Dittmar, Venkata Satagopam, PhD, Haydar Demirdizen, Michael Hundemer, MD, Luis Becker, MD, Peter Lang, MD, Gerhard Opelz, MD, Peter Terness, MD

Blood (2013) 122 (21): 4457.

https://doi.org/10.1182/blood.V122.21.4457.4457

Published: 2013

Journal Articles

Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6

Blood (2013) 121 (22): 4493–4503.

https://doi.org/10.1182/blood-2012-05-429415

Published: 2013

Includes: Supplemental data

Journal Articles

Human Multiple Myeloma and Breast Cancer Cells Evade Immune Rejection Through Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6.

Mathias Witzens-Harig, MD, Dirk Hose, MD, PhD, Simone Jünger, Christina Pfirschke, Nisit Khandelwal, Anja Seckinger, MD, Heinke Conrad, Bettina Brackertz, Thierry Reme, Brigittte Gückel, Tobias Meissner, Michael Hundemer, Anthony D Ho, MD, Jean-Francois Rossi, MD, PhD, Kai Neben, MD, Helga Bernhard, MD, Hartmut Goldschmidt, MD, Bernard Klein, Philipp Beckhove

Blood (2012) 120 (21): 2942.

https://doi.org/10.1182/blood.V120.21.2942.2942

Published: 2012

Journal Articles

Continued Response off Treatment After BRAF Inhibition in Refractory Hairy Cell Leukemia

Sascha Dietrich, MD, Jennifer Hüllein, Michael Hundemer, Nicola Lehners, MD, Alexander Jethwa, David Capper, MD, Till Acker, MD, Boyan Garvalov, PhD, Mindaugas Andrulis, MD, Carolin Blume, Julia Meissner, MD, Stefan Fröhling, MD, Christof von Kalle, MD, Hanno Glimm, MD, Anthony D. Ho, MD, Thorsten Zenz, MD

Blood (2012) 120 (21): 4600.

https://doi.org/10.1182/blood.V120.21.4600.4600

Published: 2012

Journal Articles

Achievement of CR and nCR Before and After First High-Dose Therapy Followed by Autologous Stem Cell Transplantation Is a Major Marker for Long-Term Survival in Multiple Myeloma Patients.

Hartmut Goldschmidt, Gerlinde Egerer, Ute Hegenbart, Markus Munder, Thomas Hielscher, Christiane Heiβ, Uta Bertsch, Jens Hillengaβ, Jana Schlenzka, Marc-Steffen Raab, Dirk Hose, Michael Hundemer, Kai Neben, Anthony D. Ho

Blood (2009) 114 (22): 3400.

https://doi.org/10.1182/blood.V114.22.3400.3400

Published: 2009

Journal Articles

Proliferation and Activation Patterns of Naïve, Memory and Regulatory T Cells in Patients with Multiple Myeloma During Thalidomide, Interferon-α and Bortezomib Maintenance Therapy.

Michael Hundemer, Isabelle Herth, Tobias Meissner, Dirk Hose, Anthony D Ho, M.D., Ph.D., Kai Neben, Hartmut Goldschmidt, Mathias Witzens-Harig

Blood (2009) 114 (22): 3880.

https://doi.org/10.1182/blood.V114.22.3880.3880

Published: 2009

Journal Articles

Induction of angiogenesis by normal and malignant plasma cells

Dirk Hose, Jérôme Moreaux, Tobias Meissner, Anja Seckinger, Hartmut Goldschmidt, Axel Benner, Karène Mahtouk, Jens Hillengass, Thierry Rème, John De Vos, Michael Hundemer, Maud Condomines, Uta Bertsch, Jean-François Rossi, Anna Jauch, Bernard Klein, Thomas Möhler

Blood (2009) 114 (1): 128–143.

https://doi.org/10.1182/blood-2008-10-184226

Published: 2009

Includes: Supplemental data

NARROW

The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature

Immunological Subgroups Predicting Efficacy of Elotuzumab in Multiple Myeloma Patients: Insights from the GMMG-HD6 Clinical Trial

Bone Marrow Immune Signatures in Multiple Myeloma Are Linked to Tumor Heterogeneity and Treatment Outcome

Macs - a Leukemic Stem Cell- Based Predictor of Clinical Response to Venetoclax and Other BH3 Mimetics for Acute Myeloid Leukemia

Leukemic Stem Cells of Monocytic AMLs Are Not-Resistant to BCL-2 Inhibition

Impact of Novel Therapies on CD4-T-Cell-Numbers and Infectious Complications in Patients with Relapsed/Refractory Multiple Myeloma

The Bone Marrow Microenvironment of Multiple Myeloma Long-Term Survivors at Single Cell Resolution

Characterization of Patients with Multiple Myeloma in Long- Term Remission

The Prognostic and Predictive Value of IKZF1 and IKZF3 Expression in T-Cells in Patients with Multiple Myeloma

Target Expression, Preclinical Activity and Mechanism of Action of EM801: A Novel First-in-Class Bcma T-Cell Bispecific Antibody for the Treatment of Multiple Myeloma

A Single Center Comparison Between Two Different Apheresis Systems for Peripheral Blood Stem Cell Collections

Detection and Characterization of Plasma Cell and B Cell Clones in Patients with Systemic Light Chain Amyloidosis Using Flow Cytometry

Validation of a Predictive Formula for Collection of Hematopoietic Progenitor Cells (HPC) By Leukapheresis at 2 Institutions Using 4 Different Machine Protocols

Control Of Allograft Rejection With Mitomycin C Incubated Blood Cells

Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6

Human Multiple Myeloma and Breast Cancer Cells Evade Immune Rejection Through Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6.

Continued Response off Treatment After BRAF Inhibition in Refractory Hairy Cell Leukemia

Achievement of CR and nCR Before and After First High-Dose Therapy Followed by Autologous Stem Cell Transplantation Is a Major Marker for Long-Term Survival in Multiple Myeloma Patients.

Proliferation and Activation Patterns of Naïve, Memory and Regulatory T Cells in Patients with Multiple Myeloma During Thalidomide, Interferon-α and Bortezomib Maintenance Therapy.

Induction of angiogenesis by normal and malignant plasma cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only